Alignment Healthcare CEO Kao John E sold 557,870 shares across two transactions priced from $12.68 to $12.96 per share. His reported ownership after the sales was 1,223,473 shares, giving investors a disclosed view of the executive’s remaining stake and the scale of the transaction relative to that holding.
Key Highlights
- Kao John E’s reported ownership after the transactions was 1,223,473 Alignment Healthcare shares.
- The two transactions took place on Sep 10 and Sep 11, 2026.
- Transaction code S classified both entries as open-market sales.
Alignment Healthcare, Inc. (NASDAQ: ALHC) CEO Kao John E sold 557,870 shares across two transactions, with prices ranging from $12.68 to $12.96 per share. The reported ownership figure after the sales was 1,223,473 shares.
Two Transactions at Prices Up to $12.96
The transactions took place on Sep 10 and Sep 11, 2026. The reported prices covered a range beginning at $12.68 and ending at $12.96 per share. The sales were reported across two separate transactions rather than a single entry. Kao John E’s ownership following those transactions was 1,223,473 shares.
FAQs
Q: How many Alignment Healthcare shares did Kao John E sell?
A: Alignment Healthcare CEO Kao John E sold 557,870 shares across two transactions. The reported prices ranged from $12.68 to $12.96 per share.
Q: What does the Alignment Healthcare insider sale mean for investors?
A: For investors, the reported information shows that Alignment Healthcare CEO Kao John E sold 557,870 shares across two transactions on Sep 10 and Sep 11, 2026. His reported ownership afterward was 1,223,473 shares.
Q: When did the Alignment Healthcare CEO share sales occur?
A: The two Alignment Healthcare transactions occurred on Sep 10 and Sep 11, 2026. Both transactions involved shares sold by CEO Kao John E.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.